UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial

The lancet oncology, 2016, Vol.17 (1), p.78-89

2016

Volltextzugriff (PDF)

Intestinal Macrophages Lack CD14 and CD89 and Consequently Are Down-Regulated for LPS- and IgA-Mediated Activities

The Journal of immunology (1950), 2001-09, Vol.167 (5), p.2651-2656

2001

Volltextzugriff (PDF)

Randomized phase II study of nintedanib in metastatic castration-resistant prostate cancer postdocetaxel

Anti-cancer drugs, 2014-10, Vol.25 (9), p.1081-1088

2014

Volltextzugriff (PDF)

Abstract C027: A Phase I, dose finding study of BI 754111, an anti-LAG-3 antibody, in combination with BI 754091, an anti-PD-1 antibody, in patients with advanced solid tumors: preliminary results from the microsatellite stable (MSS) metastatic colorectal cancer (mCRC) cohort

Molecular cancer therapeutics, 2019-12, Vol.18 (12_Supplement), p.C027-C027

2019

Volltextzugriff (PDF)

Phase II Trial of Weekly Alternating Sequential BIBF 1120 and Afatinib for Advanced Colorectal Cancer

Anticancer research, 2011-06, Vol.31 (6), p.2271-2281

2011

Volltextzugriff (PDF)

Isolation and purification of CD14-negative mucosal macrophages from normal human small intestine

Journal of immunological methods, 1997-03, Vol.202 (1), p.1-11

1997

Volltextzugriff (PDF)

Independent review of AGO-OVAR 12, a GCIG/ENGOT-Intergroup phase III trial of nintedanib (N) in first-line therapy for ovarian cancer (OC)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.5556-5556

2014

Volltextzugriff (PDF)

Prolactin stimulates proliferation of the glucose-dependent beta-cell line INS-1 via different IRS-proteins

Journal of the Pancreas, 2007-11, Vol.8 (6), p.739-752

2007

Volltextzugriff (PDF)

Prolonged response of relapsed high grade serous ovarian carcinoma to the oral angiokinase inhibitor nintedanib in a patient with a germline BRCA1 mutation

Gynecologic oncology case reports, 2013, Vol.3, p.7-10

2013

Volltextzugriff (PDF)

Infections in the immunopathogenesis of chronic inflammatory bowel disease

Seminars in immunology, 1998-02, Vol.10 (1), p.69-78

1998

Volltextzugriff (PDF)

Characterization of enteric functional changes evoked by in vivo anti-CD3 T cell activation

American journal of physiology. Regulatory, integrative and comparative physiology, 1999-03, Vol.276 (3), p.715-R723

1999

Volltextzugriff (PDF)

Characterization of enteric functional changes evoked by in vivo anti-CD3 T cell activation

American journal of physiology. Regulatory, integrative and comparative physiology, 1999-03, Vol.45 (3), p.R715

1999

Volltextzugriff (PDF)

Systemic caspase-inhibitors severely aggravate colitis in rodent models of colitis

Gastroenterology (New York, N.Y. 1943), 2000-04, Vol.118 (4), p.A1135-A1135

2000

Volltextzugriff (PDF)

Combined absence of perforin and FasL in perf -/- x gld mice significantly decreases anti-CD3 induced enteropathy

Gastroenterology (New York, N.Y. 1943), 2000-04, Vol.118 (4), p.A95-A95

2000

Volltextzugriff (PDF)

Prolonged response of relapsed high grade serous ovarian carcinoma to the oral angiokinase inhibitor nintedanib in a patient with a germline BRCA1 mutation

Gynecologic oncology case reports, 2012-10, Vol.3, p.7-10

2012

Volltextzugriff (PDF)

Options for REDD+ Voluntary Certification to Ensure Net GHG Benefits, Poverty Alleviation, Sustainable Management of Forests and Biodiversity Conservation

Forests, 2011-04, Vol.2 (2), p.550-577

2011

Volltextzugriff (PDF)

High rate of hypoglycemia in 6770 type 2 diabetes patients with comorbid dementia: A multicenter cohort study on 215,932 patients from the German/Austrian diabetes registry

Diabetes research and clinical practice, 2016-02, Vol.112, p.73-81

2016

Volltextzugriff (PDF)

Annual Survey of Judicial Developments Pertaining to Mergers and Acquisitions

The Business Lawyer, 2014-02, Vol.69 (2), p.477-520

the Annual Survey Working Group of the M&A Jurisprudence Subcommittee, Mergers and Acquisitions Committee, ABA Business Law Section

2014

Volltextzugriff (PDF)

Annual Survey of Judicial Developments Pertaining to Mergers and Acquisitions

The Business Lawyer, 2016-04, Vol.71 (2), p.589-632

2016

Volltextzugriff (PDF)

Annual Survey of Judicial Developments Pertaining to Mergers and Acquisitions

The Business Lawyer, 2018-03, Vol.73 (2), p.379-424

2018

Volltextzugriff (PDF)

Annual Survey of Judicial Developments Pertaining to Mergers and Acquisitions

The Business Lawyer, 2017-03, Vol.72 (2), p.431-460

Annual Survey Working Group of the M&A Jurisprudence Subcommittee, Mergers and Acquisitions Committee, ABA Business Law Section

2017

Volltextzugriff (PDF)

Annual Survey of Judicial Developments Pertaining to Mergers and Acquisitions

The Business Lawyer, 2012-02, Vol.67 (2), p.491-536

Annual Survey Working Group of the M&A Jurisprudence Subcommittee, Mergers and Acquisitions Committee

2012

Volltextzugriff (PDF)

Annual Survey of Judicial Developments Pertaining to Mergers and Acquisitions

The Business Lawyer, 2013-02, Vol.68 (2), p.509-552

Annual Survey Working Group of the M&A Jurisprudence Subcommittee, Mergers and Acquisitions Committee, ABA Section of Business Law

2013

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial

Intestinal Macrophages Lack CD14 and CD89 and Consequently Are Down-Regulated for LPS- and IgA-Mediated Activities

Randomized phase II study of nintedanib in metastatic castration-resistant prostate cancer postdocetaxel

Abstract C027: A Phase I, dose finding study of BI 754111, an anti-LAG-3 antibody, in combination with BI 754091, an anti-PD-1 antibody, in patients with advanced solid tumors: preliminary results from the microsatellite stable (MSS) metastatic colorectal cancer (mCRC) cohort

Phase II Trial of Weekly Alternating Sequential BIBF 1120 and Afatinib for Advanced Colorectal Cancer

Isolation and purification of CD14-negative mucosal macrophages from normal human small intestine

The prognostic value of tumor residuals indicated by surgeon, by radiology or an integrated approach by surgeons' assessment and pre-chemotherapy CT-scan in patients with advanced ovarian cancer: An exploratory analysis of the AGO Study led Intergroup trial AGO-OVAR 12

Independent review of AGO-OVAR 12, a GCIG/ENGOT-Intergroup phase III trial of nintedanib (N) in first-line therapy for ovarian cancer (OC)

Prolactin stimulates proliferation of the glucose-dependent beta-cell line INS-1 via different IRS-proteins

Prolonged response of relapsed high grade serous ovarian carcinoma to the oral angiokinase inhibitor nintedanib in a patient with a germline BRCA1 mutation

Infections in the immunopathogenesis of chronic inflammatory bowel disease

Characterization of enteric functional changes evoked by in vivo anti-CD3 T cell activation

Characterization of enteric functional changes evoked by in vivo anti-CD3 T cell activation

Systemic caspase-inhibitors severely aggravate colitis in rodent models of colitis

Combined absence of perforin and FasL in perf -/- x gld mice significantly decreases anti-CD3 induced enteropathy

Prolonged response of relapsed high grade serous ovarian carcinoma to the oral angiokinase inhibitor nintedanib in a patient with a germline BRCA1 mutation

Options for REDD+ Voluntary Certification to Ensure Net GHG Benefits, Poverty Alleviation, Sustainable Management of Forests and Biodiversity Conservation

High rate of hypoglycemia in 6770 type 2 diabetes patients with comorbid dementia: A multicenter cohort study on 215,932 patients from the German/Austrian diabetes registry

Annual Survey of Judicial Developments Pertaining to Mergers and Acquisitions

Annual Survey of Judicial Developments Pertaining to Mergers and Acquisitions

Annual Survey of Judicial Developments Pertaining to Mergers and Acquisitions

Annual Survey of Judicial Developments Pertaining to Mergers and Acquisitions

Annual Survey of Judicial Developments Pertaining to Mergers and Acquisitions

Annual Survey of Judicial Developments Pertaining to Mergers and Acquisitions

Suchergebnisse filtern